biocon- hrd

Download BIOCON- HRD

Post on 17-Nov-2014




4 download

Embed Size (px)



COMPANY PROFILELeading biotech firm of India and among top 20

in the world, founded in 1978 Fully integrated model from pre-clinical discovery to clinical development and through to commercialisation Employs 3454 people ( 2% attrition rate) Promoter shareholding is 61% Revenue (2009) - Rs 987.1 Cr PAT (2009) - Rs 203.8 Cr


Areas Of OperationsManufacture and development of active

pharmaceuticals ingredients (APIs) and bulk drugs :Syngene Provide contract research services to overseas and domestic customers in the following areas :Molecular biology Clinical research (diabetes, asthma, ) :


HUMAN RESOURCE MANAGEMENTIntroduction Manpower Status Recruitment and Training Performance Appraisal Compensation Package Amenities : employee friendly workplace Corporate Social Responsibility

INTRODUCTIONSeparate HR division in 2000- to provide

stimulating, enriching and rewarding experience To build an exciting and challenging career within a stimulating knowledge-driven work environment where ideas and skills are valued; where people can realise their full potential through dedicated training programmes; and where individual contribution is respected, recognised and rewarded Commitment to environment, health and

Enhance Human Talent - recognise that the

development of employees will enhance performance of company Encourage teamwork across organization Protection of and Respect for Intellectual Capital - recognise that this is a key value driver and also respect the intellectual capital of others Culture of working without hierarchies

MANPOWER STATUSYEAR 2006 2007 2008 2009( March) NUMBER OF EMPLOYEES 1839 2542 2772 3454


RECRUITMENT AND TRAININGDepartment heads prepare annual manpower

requirement Review of manpower needs every quarter Through networking and website- series of interviews Well managed training centre Executive development programmes with leading institutes Encourage professional and personal growth Helps align individual efforts with overall corporate goals.

PERFORMANCE APPRAISALPerformance Management Process : Align

individual efforts with Corporate goals Annual objective setting Annual performance review

Indicative performance rewards: Effective

performance Bonus Scheme on periodic review system.

Employee Stock Options : Excellence in

performance recognised through stock options.

Compensation & Benefits : Appreciation &

Rewards for outstanding performance . Workforce motivated

COMPOSITION OF COMPENSATION PACKAGEPerformance bonus Group medical insurance Conveyance allowance Highly subsidised luncheon facility Maternity leave Tuition fee for up to two children Contributory provident fund Retirement - pension, gratuity, superannuation Employee stock options Relocation Benefits

Biocontribute Awards

Outstanding performance is recognised and rewarded by way of special Biocontribute Awards presented annually on Biocon Day

Recognition to star performers:

Outstanding contribution, innovative contribution and significant contribution 2008- HR Leadership Award to head ,HR Biocon at Asia Pacific HR Congress

AMENITIESStimulating work environment makes daily challenges enjoyable and rewarding : Safe working environment: OHSAS : 18001: 2007 Hi! Im new- badge for newcomers Well equipped day-care centre In- house healthcare centre Round the clock transportation facilities Well-designed eco-friendly campus Spacious and efficient cafetaria Highly conducive and enabling atmosphere Well equipped gym with experienced instructor Performance rewards- individual along with team based

CORPORATE SOCIAL RESPONSIBILITYIntegrated outreach strategy that focuses on social change and empowerment of rural communities through public health, sanitation and educational programmes Company Foundation- founded in 2004 Chinnara ganita-distribution of innovative mathematics textbooks Scholarships Upgradation of infrastructure of existing government schools



MANPOWER STATUS March 31,2006 Biocon Syngene Clinigene BBPL TotalHead Count 1,225 526 60 28 1,839 1,643 754 70 75 2,542 1,634 907 133 98 2,772 1,978 1,240 137 99 3,454 March31,2007 March31,2008 March31,2009


To be an integrated biotechnology enterprise of global distinction.

Essential to this mission is excellence in: - Intellectual asset creation through discovery, research and development - State-of-the-art manufacturing capabilities - Internationally benchmarked quality and regulatory systems - New medical insight through disease specific clinical research - Customer relationship through outstanding products and services - Human resource development through training, mentoring and empowering - Management of research and business partnerships

BRIEF HISTORY OF COMPANY1978-Founded as a joint venture 1979-First Indian company to export enzymes to

USA 1994-First subsidiary established 1998-Fully owned by Indian promoters 2000-Second subsidiary set up 2003-Insulin expression in yeast system 2004- Issued IPO to raise 300 Cr 2006-First cancer drug Abraxane 2007-Joint venture company at Dubai Biotech Park 2008-Acquired 70% stake in Axicorp(German Firm) - Ranked in top 20 biotech firms by Med Ad News

PRODUCTSBiopharmaceuticalsSmall molecules : Produces anti-

diabetic agents, anti-hypertensive agents, anti-inflammatory agents, antioxidants, cardiovascular agents etc Biologicals : Biogenerics, current products include: Insulin, Streptokinase, and Monoclonal Antibodies. Dosage Forms : Therapeutic segments of cardiology and diabetes. Clinical Research Custom Research- Global Clientele


PRODUCTS OF GENMOLAffordability index of Genmol Products Genmol products are available in over 1 , 50 , 000pharmacies across India 700 + FIELD FORCE


TOP 10 BIOTECH COMPANIES OF THE WORLD1.Amgen 2.Genentech 3.Serno 4.Biogen Idec 5.UCB-Celltech 6.Genzyme 7.Gilead 8.MedImmune 9.Chiron 10.Millennium

LEADING BIOTECH COMPANIES OF INDIARank Company 1 2 3 4 5 6 7 8 9 10 Revenue (Rs crore) 2006 950.95 728 600 391.25 309.49 190.5 222 165 157.9 151.37 Serum Institute of India Biocon Panacea Biotech Monsanto Biotech Rasi Seeds Venkateshwara Hatcheries Novo Nordisk Tulip Indian Immunologicals TransAsia Biomedics 703 603 437.82 162.5 86.87 188 175 132 100 127

Revenue (Rs crore) 2005

Growth (%) 35.27 20.73 37.04 140.62 256.27 1.95 26.86 25 57.9 19.19

Delivers products and solutions to partners and

customers in over 50 countries Developed innovative & effective biomolecules in diabetology, oncology, cardiology